CROI 2019 Abstract eBook

Abstract eBook

Disclosure Index

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH COMMERCIAL CONCERNS Disclosure information is presented generally as submitted by the corresponding presenting abstract author, invited speaker, session moderator, or member of the CROI Program Committee. The individuals below provided their relevant disclosures of financial relationships with commercial entities for themselves and their spouses or partners, as well as funding provided to their institutions on their behalf (eg, for research where they are the principal investigator). The Accreditation Council for Continuing Medical Education (ACCME) defines a financial interest as an interest in any amount and defines a commercial interest as “any entity producing, marketing, re- selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical service is owned, or controlled by, an ACCME-defined commercial interest.” The information is intended to make the audience aware of speaker and contributor interests and commitments with commercial interests, enabling the audience members to form their own judgments about such associations.

Aberg, Judith Self: Consulting or advisor fees for Janssen Therapeutics, Merck & Co, Inc., ViiV Healthcare, Inc. To self, paid to my institution: Research grant/grant pending from Frontier Technologies, Gilead Sciences, GlaxoSmithKline, ViiV Healthcare, Inc. Achenbach, Chad J. Self: Consulting or advisor fees from and speaker's bureau for ViiV Healthcare, Inc.; research grant/grant pending from Gilead Sciences; membership in Abivax; board membership for Biotron Achieng, Loice Self: Speaker’s bureau for Pfizer, MSD, GlaxoSmithKline, ViiV Healthcare, Inc., Gilead Sciences Acosta, Rima K. Self: Employment at and stock/stock options in Gilead Sciences Adimora, Adaora Self: Board membership for Merck & Co, Inc.; consulting or advisor fees and research grant/grant pending from Gilead Sciences; other from ViiV Healthcare, Inc. Allavena, Clotilde To self, paid to my institution: Board membership for Janssen Therapeutics, ViiV Healthcare, Inc., Merck & Co, Inc. Alter, Galit To self, paid to my institution: Research grant/grant pending from BioProtection Systems/New Link Genetics, Gilead Sciences, Merck & Co, Inc., Pfizer, Bristol-Myers Squibb; other from Sanofi, Curevac, Janssen Therapeutics, GlaxoSmithKline Althoff, Keri, N. Self: Consulting or advisor fees from Trio Health Anderson, Peter, L. To self, paid to my institution: Research grant/grant pending from Gilead Sciences Andreatta, Kristen Self: Employment at Gilead Sciences Anthony-Gonda, Kim Self: Employment at Lentigen, a Miltenyi Biotec company Averitt, Dawn Self: Advisory board for Merck & Co, Inc. Avery, Ann K. Self: Consulting or advisor fees from and speaker's bureau for Gilead Sciences Avihingsanon, Anchalee Self: Speaker's bureau for Janssen Therapeutics Back, David To self, paid to my institution: Research grant/grant pending from AbbVie Inc., Merck & Co, Inc., Janssen Therapeutics, Gilead Sciences, ViiV Healthcare, Inc. Self: Speaker's bureau for AbbVie Inc., Merck & Co, Inc., Gilead Sciences, ViiV Healthcare, Inc. Bares, Sara H. To self, paid to my institution: Research grant/grant pending from Gilead Sciences

Baum, Marc To self, paid to my institution: Patent holder Beckwith, Curt G. Self: Research grant/grant pending from Gilead Sciences Bedimo, Roger To self, paid to my institution: Research grant/grant pending from ViiV Healthcare, Inc., Merck & Co, Inc. Self: Consulting or advisor fees from ViiV Healthcare, Inc., Merck & Co, Inc., Napo Pharmaceuticals Behrens, Georg Self: Consulting or advisor fees from ViiV Healthcare, Inc., Gilead Sciences, Janssen Therapeutics, MSD Bekker, Linda-Gail Self: Consulting or advisor fees from Merck & Co, Inc., Janssen Therapeutics, GlaxoSmithKline, ViiV Healthcare, Inc.; research grant/grant pending from Gilead Sciences; board membership for ViiV Healthcare, Inc. Benson, Constance A. To self, paid to my institution: Research grant/grant pending from Gilead Sciences; consulting or advisor fees from GlaxoSmithKline, ViiV Healthcare, Inc. Spouse or Partner: Stock/stock options in CytoDyn, Antiva Biosciences; consulting or advisor fees from VIR, Pfizer Spouse or Partner, paid to institution: Consulting or advisor fees from Gilead Sciences, Monogram Biosciences Betts, Michael R. To self, paid to my institution: Research grant/grant pending from Merck & Co, Inc. Bhattacharya, Debika Self: Other from Regeneron, AbbVie Inc. Bieniasz, Paul Self: Stock/stock options in Gilead Sciences; speaker's bureau for ViiV Healthcare, Inc. Blumenthal, Jill Self: Consulting or advisor fees from Gilead Sciences Boesecke, Christoph Self: Consulting or advisor fees from AbbVie Inc., Gilead Sciences, Janssen Therapeutics, Merck & Co, Inc., ViiV Healthcare, Inc. Bollen, Pauline To self, paid to my institution: Research grant/grant pending from EC, DG Research, 6th Framework program, Bristol- Myers Squibb, Merck & Co, Inc., ViiV Healthcare, Inc., Janssen Therapeutics N.V., Gilead Sciences Borges, Álvaro H. To self, paid to my institution: Research grant/grant pending from Lundbeckfonden Bradshaw, Daniel To self, paid to my institution: Research grant/grant pending from ViiV Healthcare, Inc., Janssen Therapeutics Brew, Bruce J. Self: Consulting or advisor fees from AbbVie Inc., ViiV Healthcare, Inc., Biogen, Merck & Co, Inc.

To self, paid to my institution: Research grant/grant pending from Biogen Brown, Dannae Self: Employment at ViiV Healthcare, Inc.; stock/stock options in GlaxoSmithKline Brumme, Zabrina Self: Stock/stock options in Pfizer Buchbinder, Susan P. To self, paid to my institution: Provision of medicine or equipment from Gilead Sciences Butt, Adeel, A. To self, paid to my institution: Research grant/grant pending from Gilead Sciences Calcagno, Andrea Self: Consulting or advisor fees from Janssen Therapeutics, Merck & Co, Inc., ViiV Healthcare, Inc. To self, paid to my institution: Research grant/grant pending from ViiV Healthcare, Inc. Cannon, Paula Self: Expert Testimony for MilliporeSigma Carlander, Christina Self: Consulting or advisor fees from GlaxoSmithKline, ViiV Healthcare, Inc., Gilead Sciences Castel, Amanda D. Self: Stock/stock options in Gilead Sciences Celum, Connie L. Self: Board membership for Merck & Co, Inc.; provision of medicine or equipment from Gilead Sciences Chaisson, Richard E. Self: Speaker's bureau for Janssen Therapeutics Spouse or Partner: Stock/stock options in Merck & Co, Inc. Chappell, Catherine A. To self, paid to my institution: Research grant/grant pending from Gilead Sciences, Merck & Co, Inc. Charpentier, Charlotte Self: Board membership for Gilead Sciences, Merck & Co, Inc. To self, paid to my institution: Research grant/grant pending from ViiV Healthcare, Inc. Chéret, Antoine Self: Research grant/grant pending from Merck & Co, Inc., Janssen Therapeutics, ViiV Healthcare, Inc.; consulting or advisor fees from Gilead Sciences, Janssen Therapeutics Chew, Kara W. To self, paid to my institution: Research grant/grant pending from Merck & Co, Inc. Coffin, John M. Self: Stock/stock options in Tocagen, Inc.; consulting or advisor fees from Tocagen, Inc. Costagliola, Dominique To self, paid to my institution: Research grant/grant pending from Janssen Therapeutics Self: Speaker's bureau for Janssen Therapeutics, Gilead Sciences

Disclosure Information

CROI 2019 432